Related Experiment Video
Updated: Jan 12, 2026

An Invasive Method for the Activation of the Mouse Dentate Gyrus by High-frequency Stimulation
Published on: June 2, 2018
Deep Brain Stimulation: Overview and Applications in the Context of Neuropsychiatric Conditions
Deirdre L Richardson1, Eric Whitney2
1Neurology, Western University of Health Sciences, Chino Hills, USA.
Deep brain stimulation (DBS) offers a promising neuromodulatory therapy for various neurological disorders by normalizing brain activity. Ongoing research explores DBS for autism spectrum disorder, depression, and Alzheimer's disease, with advances guiding target selection for improved outcomes.
Area of Science:
- Neuroscience
- Neuromodulation
- Connectomics
Background:
- Deep brain stimulation (DBS) is a neuromodulatory therapy that implants electrodes to normalize brain activity in neurological disorders.
- DBS mechanisms influence neuronal signaling, synaptic reorganization, and network connectivity at multiple scales.
- Advances in connectomics and sensing enable precise, adaptive stimulation for complex neuropsychiatric conditions.
Purpose of the Study:
- To explore the emerging applications of DBS in neuropsychiatric conditions beyond obsessive-compulsive disorder.
- To investigate the efficacy of DBS for autism spectrum disorder (ASD), treatment-refractory depression (TRD), and Alzheimer's disease (AD).
- To analyze shared neurobiological mechanisms and refine therapeutic targets using connectomic approaches.
Main Methods:
- Review of emerging research on DBS for ASD, TRD, and AD.
- Connectomic analyses to identify overlapping network dysfunctions across disorders.
- Exploration of advances in functional neuroimaging, closed-loop stimulation, and machine learning for target selection.
Main Results:
- DBS shows promise for ASD by reducing self-injurious behaviors via specific brain targets (NAc, amygdala, hypothalamus).
- DBS for TRD demonstrates significant antidepressant effects by targeting specific brain regions (SCG, MFB, VC/VS).
- DBS for AD/dementia shows potential in slowing cognitive decline through targeted stimulation (fornix, NBM).
- Connectomic analyses reveal shared cortical-subcortical network dysfunctions across these conditions.
Conclusions:
- DBS is a developing therapeutic strategy for complex neuropsychiatric conditions, with ongoing research identifying optimal brain targets.
- Connectomic insights into shared neurobiological mechanisms can guide the refinement of DBS targets.
- Advances in technology and methodology are crucial for improving DBS efficacy and expanding its application in neuropsychiatry.
More Related Videos
05:19Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
08:25Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans
Published on: May 19, 2016